- regenerative-medicine-scientistbyk-dense-ai
Reasons from potency assurance, 361 vs 351/ATMP pathways, USP <1043> ancillary tiers, G-Rex/closed CAR-T manufacture,…
Reasons from potency assurance, 361 vs 351/ATMP pathways, USP <1043> ancillary tiers, G-Rex/closed CAR-T manufacture,…